Contribution of the Indoor Environment Medical Advisor in the Management of Fibrosing Hypersensitivity Pneumonitis
Not yet recruitingOBSERVATIONAL
Enrollment
100
Participants
Timeline
Start Date
December 12, 2023
Primary Completion Date
June 12, 2026
Study Completion Date
June 12, 2026
Conditions
Hypersensitivity Pneumonitis
Trial Locations (1)
44093
CHU de Nantes, Nantes
All Listed Sponsors
lead
Nantes University Hospital
OTHER
NCT05988437 - Contribution of the Indoor Environment Medical Advisor in the Management of Fibrosing Hypersensitivity Pneumonitis | Biotech Hunter | Biotech Hunter